News|Articles|December 13, 2023
DEVELOPICK™: High-throughput developability assessment to enable efficient formulation development
Author(s)Samsung Biologics
Explore how Samsung Biologics’ DEVELOPICK™ can help mitigate development risk and identify candidates with the best potential for advancement to IND and beyond
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
